A nurse is assessing an adolescent who experienced blunt trauma to the abdomen. Which of the following findings is the nurse's priority?

Cystic fibrosis (CF) is a genetic disorder that affects the production and function of certain glands, particularly those that produce mucus and sweat. One of the key aspects of CF management is addressing the pancreatic insufficiency that occurs in many individuals with CF. Due to the impairment of the pancreas, children with CF may have difficulty digesting food properly, especially fats. This can lead to malabsorption of nutrients, poor weight gain, and other nutritional deficiencies.

Pancreatic enzyme replacement therapy is a crucial part of CF management. Pancreatic enzymes are prescribed to help the child digest and absorb essential nutrients, especially fats. The enzymes are typically given with each meal and snack to aid in the breakdown and absorption of nutrients.

The other options are not correct:

A. "We will restrict the amount of salt in our child's food."

Sodium restriction is generally not a focus in CF management unless there are specific indications for it. CF patients may have increased salt losses in sweat, but dietary sodium restriction is not a primary aspect of their care.

B. "I will limit my child's fluid intake."

Fluid intake is important for children with CF to maintain hydration and prevent dehydration. There is no specific need to limit fluid intake unless there are individualized medical reasons for doing so.

C. "I will prepare low-fat meals with limited protein for my child."

Children with CF often require a high-calorie, high-protein diet to maintain adequate nutrition and growth. Restricting fat and protein intake is not typically recommended, as these nutrients are essential for a child's development and well-being. Instead, pancreatic enzymes are used to aid in the digestion and absorption of fats and other nutrients.

For a child with hemophilia experiencing a joint injury, the best home treatment and therapy would be elevation and the application of ice to the affected joint. This approach helps reduce swelling and minimize bleeding in the joint.
Option A (factor VIII concentrates) is a treatment for hemophilia but is typically administered intravenously to replace the deficient clotting factor in the blood. It is not a home treatment for joint injuries.
Option C (nonsteroidal anti-inflammatory drugs - NSAIDs) may be used to manage pain and inflammation, but they do not address the underlying bleeding disorder in hemophilia or directly treat joint injuries.
Option D (DDAVP - synthetic vasopressin) is used in some types of hemophilia to temporarily raise factor VIII levels, but it is not typically used for joint injuries or as a home treatment.